Neural Stimulation for Hand Grasp

NCT ID: NCT04306328

Last Updated: 2021-02-25

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 2 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2020-10-15
• Study Completion Date: 2020-12-11

Brief Summary

A selective neural stimulation as the investigators propose allows to stimulate several muscles via a single electrode. Neural stimulation requires less energy for muscle activation. In our approach, 2 electrodes will be implanted above the elbow on the median and radial nerves. This considerably reduces the number of implanted elements and therefore i) the risk of infection, ii) the risk of failure, iii) the surgical risk through minimally invasive surgery.

Our main hypothesis is that multipolar neural electrical stimulation of the median nerve (flexion) and the radial nerve (extension) allows:

• on the one hand, a selective, individualized motor activation (muscle by muscle)
• on the other hand, a synergistic motor activation (association of several muscles) for the purpose of production of functional movements.

Detailed Description

Electrical stimulation of the muscles has been used for decades in rehabilitation units specializing in the treatment of spinal cord injuries. It has been shown to be effective in building muscle and preventing muscle atrophy following spinal cord injury (SCI) or stroke. It can also be used to reduce spasticity and above all to promote functionally useful motor control. It is then a Functional Electric Stimulation (FES). In the quadriplegic person marked by a severe motor deficiency of the upper limbs, FES is today the only technique allowing to restore a functional gripping movements in the case where the active muscular resources below the elbows are missing or too weak to allow tendon transfer surgery.

Like "Freehand", all the devices using FES directly stimulate the muscles (surface, intramuscular or epimysial electrodes) and therefore require a high number of internal components with a theoretical risk of infection and greater rejection. since each muscle must be activated via an electrode (up to 12 in the case of "FreeHand"). The investigators propose instead selective neural stimulation as it allows stimulating several muscles via a single electrode. Neural stimulation requires less energy for muscle activation. In our approach, 2 electrodes will be implanted above the elbow on the median and radial nerves. This considerably reduces the number of implanted elements and therefore i) the risk of infection, ii) the risk of failure, iii) the surgical risk thanks to minimally invasive surgery. The procedure consisted of placing a multi-contact cuff electrode around the radial or median nerves and observing the effects of electrical neural stimulation in terms of muscle selectivity, force produced and movement induced. In a previous study, the investigators already proved through acute intra operative testing (under Ethics Committee approval, #NCT03721861) that:

• No failure of the electrodes or of the stimulator was noted.
• For all of the 8 subjects, it was possible to selectively stimulate muscle groups to obtain the opening of the thumb and fingers, or the flexion of the thumb, fingers and obtaining possibly functional grip like the forceps with opposition of the thumb or palmar grip.

A second feasibility study (Ethics committee registration #2016-A00711-50) with 17 quadriplegic patients assessed the subject's ability to use voluntary contractions of sus lesional muscles (EMG recordings in 8 subjects) or voluntary movements of shoulders (inertial recordings in 9 subjects) to control the movements of a robotic hand or the triggering of an electrical surface stimulation of the muscles of the forearm. All of the patients managed to master the proposed interface after a short familiarization period.

On the basis of the results of these two studies, the investigator wish to take an additional step in the development of a gripping assistance device for patients with spinal cord injury:

• by proposing the implantation of two cuff electrodes with percutaneous connection on the arm of quadriplegic people. The electrodes will be kept in place for a period of 1 month before being definitively explanted. An implanted cable will connect the electrodes to an external connector.

Conditions

Quadriplegia

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Neurostimulation

Group Type: EXPERIMENTAL

Neurostimulation

Intervention Type: DEVICE

Implantation of 2 multicontact cuff electrodes in the upper limb of patients with tetraplegia and control of the stimulation by contralateral shoulder movements

Interventions

Neurostimulation

Implantation of 2 multicontact cuff electrodes in the upper limb of patients with tetraplegia and control of the stimulation by contralateral shoulder movements

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Informed consent signed
• Patient affiliated to a social security (state medical aid excepted).
• Neurological level ≥ C7
• 18 years old ≤ age ≤ 65 years old,
• complete traumatic injury: defined by an A or B score on the AIS scale. (AIS A or - complete motor deficit under injury. This is an internationally agreed standard for describing spinal cord injury)
• neurological stability (no change in muscle testing) > 6 months,
• post-injury duration > 6 months
• patients without active muscle resources for conventional tendon transfer surgery on the forearm and hand

Exclusion Criteria

• patient deprived of liberty (by judicial or administrative decision).
• adult patient who is subject to a legal protection measure or unable to express consent
• participation in another ongoing clinical trial
• pregnant or breastfeeding women or women of childbearing age without effective contraception
• spasticity and contractures in flexion or extension of the upper limbs of a destabilizing nature.
• unstable epilepsy with a notion of a epileptic seizure that occurred within the previous 12 months.
• unstable cardiovascular pathology (coronary heart disease, major hypertension, heart failure, etc.).
• infectious pathology under treatment at the inclusion visit
• wearing a pacemaker.
• dermatological problems contraindicating the application of surface electrodes.
• body weight >100 kg
• psychiatric condition and/or history contraindicating participation in research
• any contraindications to anesthesia and/or surgery
• hypersensitivity to low molecular weight heparin (LMWH) or to any of the excipients of the specialty used
• history of immune-mediated heparin-induced thrombocytopenia (HIT) within the last 100 days or presence of circulating antibodies
• clinically significant active bleeding or a condition associated with a high risk of bleeding
• electrical mapping identified as negative during the inclusion visit, i.e. with muscles revealing a rating < 4 MRC for at least one of the extensors (ECRL, ECRB, EDC, EPL) or one of the flexors (FPL, FDS, FDP).

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Institut National de Recherche en Informatique et en Automatique

OTHER

Sponsor Role: collaborator

NEURINNOV

UNKNOWN

Sponsor Role: collaborator

Centre Bouffard Vercelli - USSAP

OTHER

Sponsor Role: collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Charles FATTAL, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Locations

Service MPR: USSAP Centre Bouffard-Vercelli, Pôle Santé du

Perpignan, , France

Countries

France

References

Coste CA, William L, Fonseca L, Hiairrassary A, Andreu D, Geffrier A, Teissier J, Fattal C, Guiraud D. Activating effective functional hand movements in individuals with complete tetraplegia through neural stimulation. Sci Rep. 2022 Oct 6;12(1):16189. doi: 10.1038/s41598-022-19906-x.

Reference Type: DERIVED

PMID: 36202865 (View on PubMed)

Other Identifiers

APHP190280

Identifier Type: -

Identifier Source: org_study_id